Optimizing Management of Treatment-Resistant Schizophrenia in Japan: Promoting a Refined Clozapine Titration Protocol and Addressing the 'Clozapine Ceiling' through Glutamatergic Modulation.

IF 5.9 3区医学 Q1 CLINICAL NEUROLOGY

Psychiatry and Clinical Neurosciences Pub Date : 2026-08-01 Epub Date: 2026-06-12 DOI:10.1111/pcn.70093

Takahiko Nagamine

引用次数: 0

查看原文本刊更多论文

日本对难治性精神分裂症的优化管理：通过谷氨酸调节促进氯氮平滴定方案和解决“氯氮平天花板”问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Psychiatry and Clinical Neurosciences 医学-精神病学

CiteScore

7.40

自引率

4.20%

发文量

181

审稿时长

6-12 weeks

期刊介绍： PCN (Psychiatry and Clinical Neurosciences) Publication Frequency: Published 12 online issues a year by JSPN Content Categories: Review Articles Regular Articles Letters to the Editor Peer Review Process: All manuscripts undergo peer review by anonymous reviewers, an Editorial Board Member, and the Editor Publication Criteria: Manuscripts are accepted based on quality, originality, and significance to the readership Authors must confirm that the manuscript has not been published or submitted elsewhere and has been approved by each author